pegviosomant
Showing 1 - 1 of 1
Insulin Receptor Mutation, Partial Lipodystrophy Trial run by the National Institute of Diabetes and Digestive and Kidney
Not yet recruiting
- Insulin Receptor Mutation
- Partial Lipodystrophy
- pegviosomant
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022